ID: ALA3410741

Max Phase: Preclinical

Molecular Formula: C17H16O5

Molecular Weight: 300.31

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1ccccc1C(=O)COC(=O)c1cc(C)ccc1O

Standard InChI:  InChI=1S/C17H16O5/c1-11-7-8-14(18)13(9-11)17(20)22-10-15(19)12-5-3-4-6-16(12)21-2/h3-9,18H,10H2,1-2H3

Standard InChI Key:  CMJDMDCTNDFTNA-UHFFFAOYSA-N

Associated Targets(Human)

Krueppel-like factor 10 149 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 300.31Molecular Weight (Monoisotopic): 300.0998AlogP: 2.75#Rotatable Bonds: 5
Polar Surface Area: 72.83Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 10.07CX Basic pKa: CX LogP: 3.91CX LogD: 3.91
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.68Np Likeness Score: -0.59

References

1. Khedkar SA, Sun X, Rigby AC, Feinberg MW..  (2015)  Discovery of small molecule inhibitors to Krüppel-like factor 10 (KLF10): implications for modulation of T regulatory cell differentiation.,  58  (3): [PMID:25581017] [10.1021/jm5018187]
2.  (2017)  Use of small molecule inhibitors to klf10 for modulation of t regulatory cells and cancer immunotherapy,